Sign up to save your podcasts
Or
Share Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast
The Stock Day Podcast welcomed Acasti Pharma Inc. (ACST)(“the Company”), a specialty pharma company with drug delivery technologies and novel drug candidates addressing rare and orphan diseases. CEO of the Company, Jan D’Alvise, joined Stock Day host Sever Copley.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View all episodes
By Stock Day Media
4.4
3131 ratings
The Stock Day Podcast welcomed Acasti Pharma Inc. (ACST)(“the Company”), a specialty pharma company with drug delivery technologies and novel drug candidates addressing rare and orphan diseases. CEO of the Company, Jan D’Alvise, joined Stock Day host Sever Copley.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
More shows like Stock Day Media
View all
Bad Friends
14,164 Listeners